Bioxytran Highlights Newly Published Research on Real-Time Tissue Oxygenation Monitoring Relevant to BXT-25 Development
BOSTON, MASSACHUSETTS — May 29, 2026 — Bioxytran Inc. (OTCQB: BIXT), a biotechnology company focused on carbohydrate-based therapeutics and oxygen therapeutics, today highlighted the publication of a newly released scientific book that may provide valuable scientific context for future evaluation approaches related to its investigational oxygen therapeutic, BXT-25.
June 22, 2026